DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

45 hedge funds and large institutions have $39.5M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-5
Holders Change %
-10%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
15
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
1
EcoR1 Capital
California
$1.3M
2
PAI
2
Palo Alto Investors
California
$1.64M
3
BlackRock
3
BlackRock
New York
$443K
4
SM
4
Sabby Management
Florida
$680K
5
6CM
5
683 Capital Management
New York
$2.72M

Top Sellers

1
A
1
Abingworth
United Kingdom
$0
2
AFM
2
Anson Funds Management
Texas
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
BCM
5
Bourgeon Capital Management
Connecticut
$46K
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
51
A.R.T. Advisors
New York
– -$32K -11,256 Closed
1 2
3